Forward Pharma A/S Announces Termination of its American Depositary Receipts (“ADR”) Facility

2024-01-08

COPENHAGEN, Denmark, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Forward Pharma A/S (“Forward” or the “Company”) today announced that its Board of Directors has approved a termination of the Deposit Agreement, dated October 14, 2014, among Forward Pharma A/S (Forward Pharma), the Depositary Bank of New York Mellon, and Owners and Holders of ADRs.

As a result, the existing ADR facility will be terminated effective at 5:00 PM (Eastern Time) on February 5, 2024.

Kindly see additional information at the website of the Depositary Bank of New York Mellon (https://www.adrbnymellon.com/files/ad1136444.pdf).

Forward Pharma A/S Investor Relations Contact:

Investor Relations

investors@forward-pharma.com

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构